Hofseth Biocare ASA (HBC) — Long-term Investment Intensity
Hofseth Biocare ASA (HBC) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of Nkr1.73 Million represent 0.6% of total assets of Nkr293.01 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check HBC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hofseth Biocare ASA Long-term Investment Intensity (2014–2019)
This chart shows how Hofseth Biocare ASA's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of Nkr1.73 Million against total assets of Nkr293.01 Million NOK. Explore HBC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Hofseth Biocare ASA (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Hofseth Biocare ASA from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Hofseth Biocare ASA worth.
| Year | LT Investment Intensity | LT Investments (NOK) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.6% | Nkr1.73 Million | Nkr293.01 Million | ▼ -1.0 pp |
| 2018 | 1.5% | Nkr2.91 Million | Nkr187.94 Million | ▼ -0.4 pp |
| 2017 | 2.0% | Nkr3.65 Million | Nkr184.24 Million | ▲ +1.4 pp |
| 2016 | 0.6% | Nkr960.00K | Nkr159.35 Million | ▼ -0.1 pp |
| 2015 | 0.7% | Nkr1.44 Million | Nkr193.35 Million | ▲ +0.3 pp |
| 2014 | 0.4% | Nkr886.00K | Nkr217.87 Million | — |